Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04403464
Other study ID # B403201316810e
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 26, 2020
Est. completion date December 20, 2022

Study information

Verified date June 2022
Source Université Catholique de Louvain
Contact Yannick Bleyenheuft, Professor
Phone +32 2 764 93 49
Email yannick.bleyenheuft@uclouvain.be
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Recent research has shown that interventions with assistive technologies lead to an improvement in the motor and functional abilities of children with cerebral palsy (CP). REAtouch® is a new interactive interface based on motor skill learning principles. Its efficiency during intensive motor skill learning interventions has never been tested in children with bilateral cerebral palsy. Therefore, the study aims to investigate the efficiency of using a virtual reality tool to provide a motor skill learning intervention in a randomized trial.


Description:

Recent research has shown that interventions with assistive technologies could lead to an improvement in the motor and functional abilities of children with cerebral palsy (CP). However they usually miss the functional motor skill learning qualities to match the changes observed in high intensity motor skill learning based interventions.REAtouch® is a new interactive interface based on motor skill learning principles that could be implemented in intensive interventions. Therefore, the study aims to investigate the effects of intensive interventions with or without the interface on the motor and functional abilities of children with bilateral CP.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date December 20, 2022
Est. primary completion date November 20, 2022
Accepts healthy volunteers No
Gender All
Age group 5 Years to 18 Years
Eligibility Inclusion Criteria: - Diagnosed bilateral cerebral palsy, - MACS levels from I to III, - GMFCS levels from I to III, - Ability to follow instructions and complete testing. Exclusion Criteria: - Orthopedic surgery, botulinum toxin injections or another unusual intervention less than 6 months before or within the study period. - Unstable seizure - Severe visual or cognitive impairments likely to interfere with intervention or testing session completion

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
HABIT-ILE with REAtouch®
65h HABIT-ILE including 30h REAtouch®
HABIT-ILE without REAtouch®
65h HABIT-ILE

Locations

Country Name City State
Belgium Institute of Neuroscience, UCLouvain Brussels

Sponsors (1)

Lead Sponsor Collaborator
Université Catholique de Louvain

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in Gross Motor Function Measure (GMFM-66): The GMFM has been developed to measure the change in gross motor function over time in children with cerebral palsy. pre-camp (1 week before), post-camp (1 week after), 3 months follow- up
Primary Changes in ABILHAND-Kids Questionnaire This ABILHAND-Kids Questionnaire has been developed to assess a child's unimanual and bimanual upper limb activities. It ranges from - 6 to +6 logits (higher score means better performance). pre-camp (1 week before), post-camp (1 week after), 3 months follow- up
Secondary Changes in Test of Arm Selective Control (TASC) The TASC is an upper limb selective motor control evaluation tool including eight motions in each arm and up to three attempts are allowed for each motion. After completion of the best attempt, points ranging from 0 (absent), 1 (impaired) to 2 (normal) are recorded for each joint depending on the movement properties and descriptors of the test. pre-camp (1 week before), post-camp (1 week after), 3 months follow- up
Secondary Changes in Selective Control Assessment of the Lower Extremity (SCALE) The SCALE was designed to evaluate lower limb selective motor control of children with cerebral palsy. The SCALE includes testing of five reciprocal lower extremity movements. SVMC is graded at each joint as 'Normal' (2 points), 'Impaired' (1 point), or 'Unable' (0 points). pre-camp (1 week before), post-camp (1 week after), 3 months follow- up
Secondary Changes in 6 Minutes Walking Test (6MWT) The 6 Minutes Walking Test measures the distance that the patient walk as much as possible within a period of 6-minutes in a 30 meters long corridor. pre-camp (1 week before), post-camp (1 week after), 3 months follow- up
Secondary Changes in Box and Blocks test (BBT) The BBT is a test of gross manual dexterity. Each hand is tested individually and the BBT is scored through the number of blocks carried over the partition from one part to another part of a box during the one-minute trial period. pre-camp (1 week before), post-camp (1 week after), 3 months follow- up
Secondary Changes in Jebsen-Taylor Test The Jebsen-Taylor Test assesses uni-manual hand function, through 7 subtests simulating daily life activities. The test assesses speed, not quality of performance and time to complete each activity is reported using a stopwatch. pre-camp (1 week before), post-camp (1 week after), 3 months follow- up
Secondary Changes in Modified Cooper test The Modified Cooper test is a modified version of The Manual Form Perception Test, which evaluates stereognosis through 16 objects. Both hands are tested separately and time to recognise the objects is reported using a stopwatch. pre-camp (1 week before), post-camp (1 week after), 3 months follow- up
Secondary Changes in ACTIVLIM-CP Questionnaire The ACTIVLIM-CP Questionnaire measures a patient's ability to perform daily activities requiring the use of the upper and/or the lower limbs through 42 items specific to patients with cerebral palsy. It ranges from - 5 to +5 logits (higher score means better performance). pre-camp (1 week before), post-camp (1 week after), 3 months follow- up
Secondary Changes in ABILOCO-Kids Questionnaire The ABILOCO-Kids Questionnaire measures a patient's ability to perform daily activities requiring the use of the lower limbs through 10 items specific to patients with cerebral palsy. It ranges from - 4 to +4 logits (higher score means better performance). pre-camp (1 week before), post-camp (1 week after), 3 months follow- up
Secondary Changes in Pediatric Evaluation of Disability Inventory Computer Adaptive Test (PEDI-CAT) The PEDI-CAT is the new version of the Pediatric Evaluation of Disability Inventory (PEDI). The PEDI-CAT is comprised of 276 functional activities acquired throughout infancy, childhood and young adulthood. Based on the nternational Classification of Functioning, Disability and Health for Children and Youth (ICF-CY) model, the PEDI-CAT contents provide information about the activities and participation component. It ranges from 0 to 100% (higher score means better performance). pre-camp (1 week before), post-camp (1 week after), 3 months follow- up
Secondary Changes in Canadian Occupational Performance Measure (COPM) The COPM measures the patient's self-perception of occupational performance and satisfaction of it in daily activities over time. It ranges from 1 to 10 (higher score means better performance). pre-camp (1 week before), post-camp (1 week after), 3 months follow- up
Secondary Changes in Both Hands Assessment (BoHA) The BoHA is a videotaped tool measuring how effectively children with bilateral CP use both hands in bimanual activities. pre-camp (1 week before), post-camp (1 week after), 3 months follow- up
Secondary Changes in Executive Functions Cognitive functions of the children will be assessed by Stroop task and Flanker task. pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
Secondary Changes in spatial parameters of the gait (Kinematics assessments) Through a 3D motion system, we measure the stride length (meters), step length (meters) and step width (meters). pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
Secondary Changes in temporal parameters of the gait (Cycle time) Through a 3D motion system, we measure the cycle of gait time (seconds). pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
Secondary Changes in temporal parameters of the gait (Stance time) Through a 3D motion system, we measure the stance time (percentage of the total gait cycle). pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
Secondary Changes in temporal parameters of the gait (Swing time) Through a 3D motion system, we measure the swing time (percentage of the total gait cycle). pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
Secondary Changes in temporal parameters of the gait (Stride) Through a 3D motion system, we measure the gait cadence (stride per minute). pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
Secondary Changes in temporal parameters of the gait (Velocity) Through a 3D motion system, we measure the gait velocity (meter/second). pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
Secondary Changes in temporal parameters of the gait (Acceleration) Through a 3D motion system, we measure the gait acceleration (meters/second^2). pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
Secondary Changes in spatial parameters of the upper extremity (Straightness) Through a 3D motion system, we measure the straightness (percentage of upper extremity trajectory during a reaching task). pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
Secondary Changes in spatial parameters of the upper extremity (Smoothness) Through a 3D motion system, we measure the smoothness (variability of the movement during a reaching task) pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
Secondary Changes in temporal parameters of the upper extremity (Kinematics assessments) Through a 3D motion system, we measure the time from onset to end of the task (seconds). the task consists in a reaching task. pre-camp (1 week before), post-camp (1 week after), 3 months follow-up
See also
  Status Clinical Trial Phase
Recruiting NCT05317234 - Genetic Predisposition in Cerebral Palsy N/A
Recruiting NCT05576948 - Natural History of Cerebral Palsy Prospective Study
Completed NCT04119063 - Evaluating Wearable Robotic Assistance on Gait Early Phase 1
Completed NCT03264339 - The Small Step Program - Early Intervention for Children With High Risk of Developing Cerebral Palsy N/A
Completed NCT05551364 - Usability and Effectiveness of the ATLAS2030 Exoskeleton in Children With Cerebral Palsy N/A
Completed NCT03902886 - Independent Walking Onset of Children With Cerebral Palsy
Recruiting NCT05571033 - Operant Conditioning of the Soleus Stretch Reflex in Adults With Cerebral Palsy N/A
Not yet recruiting NCT04081675 - Compliance in Children With Cerebral Palsy Supplied With AFOs
Completed NCT02167022 - Intense Physiotherapies to Improve Function in Young Children With Cerebral Palsy N/A
Completed NCT04012125 - The Effect of Flexible Thoracolumbar Brace on Scoliosis in Cerebral Palsy N/A
Enrolling by invitation NCT05619211 - Piloting Movement-to-Music With Arm-based Sprint-Intensity Interval Training Among Children With Physical Disabilities Phase 1
Completed NCT04489498 - Comparison of Somatometric Characteristics Between Cerebral Palsy and Normal Children, Cross-sectional, Multi Center Study
Completed NCT03677193 - Biofeedback-enhanced Interactive Computer-play for Youth With Cerebral Palsy N/A
Recruiting NCT06450158 - Robot-assisted Training in Children With CP N/A
Completed NCT04093180 - Intensive Neurorehabilitation for Cerebral Palsy N/A
Completed NCT02909127 - The Pediatric Eating Assessment Tool
Not yet recruiting NCT06377982 - Human Umbilical Cord Blood Infusion in Patients With Cerebral Palsy Phase 1
Not yet recruiting NCT06007885 - Examining Capacity Building of Youth With Physical Disabilities to Pursue Participation Following the PREP Intervention. N/A
Not yet recruiting NCT03183427 - Corpus Callosum Size in Patients With Pineal Cyst N/A
Active, not recruiting NCT03078621 - Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Cerebral Palsy Phase 1/Phase 2